{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T00:38:52Z","timestamp":1792975132159,"version":"4.5.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,31]]},"DOI":"10.7759\/cureus.68354","type":"journal-article","created":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T06:27:08Z","timestamp":1725172028000},"source":"Crossref","is-referenced-by-count":1,"title":["Systemic Lupus Erythematosus Presenting as Isolated Thrombocytopenia: A Case Report and Review of the Literature"],"prefix":"10.7759","author":[{"given":"Sophia","family":"Tahir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naufin N","family":"Ashraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":".","family":"Rizwanullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hashem","family":"Elessawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohail","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samah Badr","family":"Hamad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waqar","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2005.00526.x","article-title":"Acquired thrombotic thrombocytopenic purpura as the presenting symptom of systemic lupus erythematosus. Successful treatment with plasma exchange and immunosuppression - report of two cases","volume":"75","author":"Starck M","year":"2005","unstructured":"Starck M, Abedinpour F, Dendorfer U, Wagner-Czekalla J, Pachmann M, Mann JF, Nerl C. Acquired thrombotic thrombocytopenic purpura as the presenting symptom of systemic lupus erythematosus. Successful treatment with plasma exchange and immunosuppression - report of two cases. Eur J Haematol. 2005, 75:436-40. 10.1111\/j.1600-0609.2005.00526.x","journal-title":"Eur J Haematol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2013.03.015","article-title":"Autoimmunity and novel therapies in immune-mediated thrombocytopenia","volume":"50","author":"Yehudai D","year":"2013","unstructured":"Yehudai D, Toubi E, Shoenfeld Y, Vadasz Z. Autoimmunity and novel therapies in immune-mediated thrombocytopenia. Semin Hematol. 2013, 50:S100-8. 10.1053\/j.seminhematol.2013.03.015","journal-title":"Semin Hematol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.5152\/eurjrheum.2023.23069","article-title":"Thrombocytopenia in patients with systemic lupus erythematosus","volume":"10","author":"Pamuk ON","year":"2023","unstructured":"Pamuk ON. Thrombocytopenia in patients with systemic lupus erythematosus. Eur J Rheumatol. 2023, 10:159-62. 10.5152\/eurjrheum.2023.23069","journal-title":"Eur J Rheumatol"},{"key":"ref4","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V56.3.329.329","article-title":"Autoimmune thrombocytopenic purpura","volume":"56","author":"Karpatkin S","year":"1980","unstructured":"Karpatkin S. Autoimmune thrombocytopenic purpura. Blood. 1980, 56:329-43.","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2017.04.012","article-title":"Pathogenesis of immune thrombocytopenia","volume":"16","author":"Audia S","year":"2017","unstructured":"Audia S, Mah\u00e9vas M, Samson M, Godeau B, Bonnotte B. Pathogenesis of immune thrombocytopenia. Autoimmun Rev. 2017, 16:620-32. 10.1016\/j.autrev.2017.04.012","journal-title":"Autoimmun Rev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/s0049-0172(98)80024-3","article-title":"Autoimmune thrombocytopenia in primary antiphospholipid syndrome and systemic lupus erythematosus: the response to splenectomy","volume":"28","author":"Hakim AJ","year":"1998","unstructured":"Hakim AJ, Machin SJ, Isenberg DA. Autoimmune thrombocytopenia in primary antiphospholipid syndrome and systemic lupus erythematosus: the response to splenectomy. Semin Arthritis Rheum. 1998, 28:20-25. 10.1016\/s0049-0172(98)80024-3","journal-title":"Semin Arthritis Rheum"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3109\/09537101003735564","article-title":"Thrombocytopenia in patients with systemic lupus erythematosus: significant in the clinical implication and prognosis","volume":"21","author":"Zhao H","year":"2010","unstructured":"Zhao H, Li S, Yang R. Thrombocytopenia in patients with systemic lupus erythematosus: significant in the clinical implication and prognosis. Platelets. 2010, 21:380-5. 10.3109\/09537101003735564","journal-title":"Platelets"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.20970","article-title":"Risk factors for future development of systemic lupus erythematosus in children with idiopathic thrombocytopenic purpura","volume":"47","author":"Hazzan R","year":"2006","unstructured":"Hazzan R, Mukamel M, Yacobovich J, Yaniv I, Tamary H. Risk factors for future development of systemic lupus erythematosus in children with idiopathic thrombocytopenic purpura. Pediatr Blood Cancer. 2006, 47:657-9. 10.1002\/pbc.20970","journal-title":"Pediatr Blood Cancer"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-007-0031-y","article-title":"Prevalence and clinical significance of elevated antinuclear antibody test in children and adult patients with idiopathic thrombocytopenic purpura","volume":"24","author":"Altintas A","year":"2007","unstructured":"Altintas A, Ozel A, Okur N, Okur N, Cil T, Pasa S, Ayyildiz O. Prevalence and clinical significance of elevated antinuclear antibody test in children and adult patients with idiopathic thrombocytopenic purpura. J Thromb Thrombolysis. 2007, 24:163-8. 10.1007\/s11239-007-0031-y","journal-title":"J Thromb Thrombolysis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1542\/pir.14-5-194","article-title":"A clinical overview of systemic lupus erythematosus in childhood","volume":"14","author":"Lang BA","year":"1993","unstructured":"Lang BA, Silverman ED. A clinical overview of systemic lupus erythematosus in childhood. Pediatr Rev. 1993, 14:194-201. 10.1542\/pir.14-5-194","journal-title":"Pediatr Rev"},{"key":"ref11","article-title":"Contemporary concepts of autoimmunity and laboratory tests for the evaluation of autoimmune diseases","volume":"43","author":"Nakamura RM","year":"1995","unstructured":"Nakamura RM. Contemporary concepts of autoimmunity and laboratory tests for the evaluation of autoimmune diseases. Rinsho Byori. 1995, 43:601-24.","journal-title":"Rinsho Byori"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2010.12.008","article-title":"Development of quality indicators to evaluate the monitoring of SLE patients in routine clinical practice","volume":"10","author":"Mosca M","year":"2011","unstructured":"Mosca M, Tani C, Aringer M, et al.. Development of quality indicators to evaluate the monitoring of SLE patients in routine clinical practice. Autoimmun Rev. 2011, 10:383-8. 10.1016\/j.autrev.2010.12.008","journal-title":"Autoimmun Rev"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-103-4-548","article-title":"Fluorescent antinuclear antibodies and anti-SS-A\/Ro in patients with immune thrombocytopenia subsequently developing systemic lupus erythematosus","volume":"103","author":"Anderson MJ","year":"1985","unstructured":"Anderson MJ, Peebles CL, McMillan R, Curd JG. Fluorescent antinuclear antibodies and anti-SS-A\/Ro in patients with immune thrombocytopenia subsequently developing systemic lupus erythematosus. Ann Intern Med. 1985, 103:548-50. 10.7326\/0003-4819-103-4-548","journal-title":"Ann Intern Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830320205","article-title":"Antinuclear antibodies in patients with chronic idiopathic autoimmune thrombocytopenia followed 2-30 years","volume":"32","author":"Panzer S","year":"1989","unstructured":"Panzer S, Penner E, Graninger W, Schulz E, Smolen JS. Antinuclear antibodies in patients with chronic idiopathic autoimmune thrombocytopenia followed 2-30 years. Am J Hematol. 1989, 32:100-3. 10.1002\/ajh.2830320205","journal-title":"Am J Hematol"},{"key":"ref15","article-title":"High-titer antinuclear antibodies, anti-SSA\/Ro antibodies and anti-nuclear RNP antibodies in patients with idiopathic thrombocytopenic purpura","volume":"71","author":"Kurata Y","year":"1994","unstructured":"Kurata Y, Miyagawa S, Kosugi S, et al.. High-titer antinuclear antibodies, anti-SSA\/Ro antibodies and anti-nuclear RNP antibodies in patients with idiopathic thrombocytopenic purpura. Thromb Haemost. 1994, 71:184-7.","journal-title":"Thromb Haemost"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2008.12.005","article-title":"Pathobiology of secondary immune thrombocytopenia","volume":"46","author":"Cines DB","year":"2009","unstructured":"Cines DB, Liebman H, Stasi R. Pathobiology of secondary immune thrombocytopenia. Semin Hematol. 2009, 46:S2-14. 10.1053\/j.seminhematol.2008.12.005","journal-title":"Semin Hematol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-021-01553-7","article-title":"Thrombopoietin receptor agonists (TPO-RAs): drug class considerations for pharmacists","volume":"81","author":"Gilreath J","year":"2021","unstructured":"Gilreath J, Lo M, Bubalo J. Thrombopoietin receptor agonists (TPO-RAs): drug class considerations for pharmacists. Drugs. 2021, 81:1285-305. 10.1007\/s40265-021-01553-7","journal-title":"Drugs"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2019.1636644","article-title":"Current and emerging treatments for immune thrombocytopenia","volume":"12","author":"Dou X","year":"2019","unstructured":"Dou X, Yang R. Current and emerging treatments for immune thrombocytopenia. Expert Rev Hematol. 2019, 12:723-32. 10.1080\/17474086.2019.1636644","journal-title":"Expert Rev Hematol"},{"key":"ref19","article-title":"Treatment of severe immune thrombocytopenia associated with systemic lupus erythematosus: 59 cases","volume":"29","author":"Arnal C","year":"2002","unstructured":"Arnal C, Piette JC, L\u00e9one J, et al.. Treatment of severe immune thrombocytopenia associated with systemic lupus erythematosus: 59 cases. J Rheumatol. 2002, 29:75-83.","journal-title":"J Rheumatol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.033100","article-title":"Lupus thrombocytopenia: clinical implications and prognostic significance","volume":"64","author":"Ziakas PD","year":"2005","unstructured":"Ziakas PD, Giannouli S, Zintzaras E, Tzioufas AG, Voulgarelis M. Lupus thrombocytopenia: clinical implications and prognostic significance. Ann Rheum Dis. 2005, 64:1366-9. 10.1136\/ard.2004.033100","journal-title":"Ann Rheum Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/289183-systemic-lupus-erythematosus-presenting-as-isolated-thrombocytopenia-a-case-report-and-review-of-the-literature","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T06:27:15Z","timestamp":1725172035000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/289183-systemic-lupus-erythematosus-presenting-as-isolated-thrombocytopenia-a-case-report-and-review-of-the-literature"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,31]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.68354","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,31]]}}}